Predictive value of cystic brosis transmembrane conductance regulator (CFTR) in the diagnosis of gastric cancer Abstract Purpose: Gastric cancer is associated with poor prognosis. e high mortality rate of gastric cancer is mainly attributed to late detection, so diagnosis and treatment are crucial to decreasing mortality. e purpose of this study was to examine the predictive accuracy and discriminative ability of cystic brosis transmembrane conductance regulator (CFTR) in gastric cancer patients, in addition to the classical cancer tumor biomarkers carbohydrate antigen 199 (CA199) and carcinoembryonic antigen (CEA).
Despite decreasing incidence and mortality, gastric cancer (GC) is the fourth most common cancer and the second most common cause of cancer-related death worldwide [1, 2] . In China, the incidence and mortality rates of GC were 35.02 and 26.08 per 100,000 people in 2006, placing it second to lung cancer [3] . e initial diagnosis of GC is o en delayed because up to 80% of patients are asymptomatic during the early stages of the disease [4] . For this reason, early diagnosis and treatment are crucial to reducing mortality in patients with GC. Since the last century, numerous tumor biomarkers have been discovered for the detection of malignancy. Carbohydrate antigen 199 (CA199) and carcinoembryonic antigen (CEA) are currently the most commonly used biomarkers for diagnosis of GC and it has been recommended that the serum levels of CA199 and CEA be monitored for detection and evaluation of GC [5, 6] . Other studies have shown that these biomarkers are not e ective in the detection of GC due to their relatively poor diagnostic sensitivity and speci city [7, 8] . For this reason, novel tumor biomarkers are required for the screening, diagnosis and determining the prognosis of GC.
In our previously proteomics study, cystic brosis transmembrane conductance regulator (CFTR), a glycoprotein with 1480 amino acids, was found to be highly expressed in leukocyte and to have a strong association with innate immunity [9] . CFTR is a cAMP-activated ATP-gated anion channel that transports chloride and thiocyanate ions across epithelial cell membranes. Any defect in CFTR expression and function may lead to various pathological conditions, especially chronic in ammatory diseases [10] [11] [12] [13] [14] . Some studies have con rmed the role of CFTR in chronic lung infections with mucoid Pseudomonas aeruginosa [11, 12] , while other studies have demonstrated that variations of CFTR gene may increase or decrease the risk of a variety of in ammation-associated cancers, including lung cancer and pancreatic cancer [13] [14] . Since both CFTR and cancers are closely-associated with chronic in ammation, it would be interesting to determine whether there is a functional interaction between CFTR and cancers. We hypothesized that CFTR may prove useful for detection of cancers.
e aim of the present study was to investigate whether CFTR in serum was helpful for detection of GC, either alone or in combination with the classical GC biomarkers (CA199 and CEA). e association between serum concentration of CFTR and clinicopathological parameters was also explored.
Materials and Methods

Patients and specimens
Ethical statement e study was performed in the Gastrointestinal Department of the First A liated Hospital of Anhui Medical University. Study protocols were approved by the medical ethics committee of the First A liated Hospital of Anhui Medical University. All participants were asked to donate blood samples for the current study and to provide their written informed consent to participate in this study. e complete protection of their personal data was agreed in a written form.
Sample collection
Cases consisted of patients in whom gastric carcinoma was present. Of the 78 patients who were diagnosed with gastric carcinoma, seven patients were in Stage I, 26 in Stage II, 31 in Stage III and 14 in Stage IV. Controls were normal, healthy people (n=88). Any participant who had a history of serious or chronic disease, such as sepsis, diabetes mellitus, hypertension or immunologic disease, was excluded from the study.
e serum samples were obtained on the morning of the day of surgery, before any treatment. Peripheral blood samples were drawn by venipuncture a er overnight fasting between 8:00 p.m. and 8:30 a.m. Serum samples were centrifuged at 1,500 g at ambient temperature for 45 min and then stored at -80ºC.
CFTR, CA199, and CEA measurement
Serum levels of CFTR (Uscn, CHN), CA199 and CEA (Abcam, UK) were determined by enzyme-linked immunosorbent assay (ELISA) in accordance with the kit manufacturer's instructions. For CFTR, the assay has a detection limit of 0.15 ng/mL and a dynamic range of up to10 ng/mL. e upper limit of normal reference for CA199 is 600 U/mL and 250ng/ mL for CEA.
Data analysis and statistics
Spearman's rank correlation coe cient was used to investigate correlations among biomarkers and between age and biomarkers. e Kruskal-Wallis test, a nonparametric method, was used to examine the relationship among biomarkers and tumor characteristics. Logistic regression was performed to calculate the odds ratio (OR) between biomarkers and case status. Receiver operating characteristic curve (ROC) analysis was performed to evaluate the diagnostic value of the markers in GC.
For each ROC curve, the area under the curve (AUC) was calculated. To determine the whether a given marker panel could lead to improved performance, ROC analysis was rst conducted on individual markers and then on combinations of markers. All analyses were performed using SPSS so ware (version 16.0; SPSS inc., Chicago, IL, U.S.), and P<0.05 was considered statistically signi cant.
Results
During the study period, a total of 78 serum samples from GC patients and 88 serum samples from healthy adults were evaluated. Of the GC patients, 56 (71.8%) were male and the mean age was 62.6±10.2 years. Of the control subjects, 55 (62.5%) were male and the mean age was 59.8±9.3 years. ere were no di erences with regards to gender (P=0.206) or age (P=0.079) between the two groups.
Correlations among biomarkers
Spearman's rank correlation coe cients were used to assess the correlations among biomarkers, and results are listed in Table 1 . In cases, CFTR was found to be strongly correlated with CA199 (P<0.001), but in controls CFTR was only weakly correlated with CEA (P=0.04) and CA199 (P=0.003).
Association of biomarkers with age
Because age is an important factor in tumor genesis, an experiment was performed to determine whether CA199, CEA and CFTR levels varied with age. No change in CA199 or CEA concentrations with age was observed for either patients or controls; however, CFTR levels were found to increase along with age in patients but not in controls (Table 2) .
Relationship between biomarkers and tumor characteristics in cases
Kruskal-Wallis testing was used to examine the relationship among biomarkers (CFTR, CA199 and CEA) and tumor characteristics such as age, tumor stage (diameter, grade, histology, ratio of positive lymph nodes to total number of lymph nodes) and body mass index (BMI). e results are shown in Table 3 . CFTR showed strong positive correlation with age (P=0.015). Both CFTR and CA199 were found to be signicantly associated with stage, but CEA showed only limited association with stage. No statistically signi cant relationship was observed between biomarkers and BMI. Figure 1 shows the distribution of three biomarkers in this study. e nonparametric Mann-Whitney test showed the median value of CFTR in healthy volunteers to be markedly lower than that in patients with GC (2.37 vs. 5.25 ng/mL; P<0.0001). A similar tendency was also observed in CA199 (16.67 vs. 86.36 U/mL; p<0.0001) and CEA (2.88 vs. 11.0 ng/ mL; P<0.0001). A logistic regression model was then used to investigate the correlation between biomarkers and GC.
Connection of biomarkers with GC
rough this univariate linear analysis, all three biomarkers, CFTR, CA199 and CEA, were found to be predictive of GC. Another logistic regression analysis was performed, this time using a stepwise method, and only CFTR and CA199 were found to be independent predictive factors of GC. e results of the logistic regression analysis are shown in Table 4 .
Diagnostic values of three biomarkers
e diagnostic value of the three biomarkers was evaluated with ROC curve analysis (Fig. 2) . Calculations showed that CEA had the lowest score (AUC: 0.715), CA199 had a moderate score (AUC: 0.824) and CFTR had the best performance (AUC: 0.851). Combining CFTR, CA199 and CEA yielded the highest ROC curve, with an AUC of 0.875. Combining any two of the three biomarkers did not result in any improvement in ROC curves relative to combining CFTR, CA199, and CEA (Table 5) .
Discussion
In the present study, the serum level of CFTR in GC patients was markedly higher than that in healthy controls. ere are two possible reasons for this. First, GC cells, which are antigens within the body, activate the inherent immune system. A erward, the expression of CFTR in the neutrophils increases signi cantly to kill tumor cells by releasing considerable numbers of chloride ions. Second, CFTR may act as a pattern recognition molecule and inhibit the process of tumor proliferation. Previous studies have shown that CFTR exists on surfaces of epithelial cells in the airway, gut and exocrine glands and can also be found in leukocytes [15, 16] . If CFTR dysfunction occurs in the lung, the chemical composition of airway secretions may also be disrupted. is abnormal airwaysecretions may disable antimicrobial peptides, preventing them from responding to any pathogenic invasion of the surface of the airway, which further increases the susceptibility of the host to P. aeruginosa and other infections [17] [18] [19] . In a study on the mechanism of P. aeruginosa infection in lungs of cystic brosis patients, Pier et al. proposed that CFTR may be an epithelial cell receptor for P. aeruginosa and that CFTR peptides 108-117 may bind to the conserved outer-core oligosaccharide of the bacterium [20] . In this sense, CFTR serves as a pattern recognition molecule, although with a more limited recognition of bacterial ligands than other pattern recognition molecules [21] . In the dextran sodium sulfate-induced colitis murine model, CFTR de ciency decreased the innate immunity of the biliary epithelium and reduced its tolerance to endotoxin, resulting in a Src-dependent in ammatory response through TLR4 and NF-кB [22] .
ere have been a few studies on CFTR expression in GC. In the eld of lung cancer research, Naren et al. showed that CFTR is located at the apical surface of plasma membrane in polarized lung epithelial cells. Functional coupling has been shown between CFTR and MRP2 (multidrug resistance protein-2), which improves the function of CFTR chloride channels in cultured lung epithelial cells [23] . Furthermore, changes in cystic brosis have been shown to be associated with increased risk of developing pancreatic cancer. e two commonest mutations of CFTR were found to be the ΔF508 mutation and the 5T polymorphism. F508 mutation gives rise to the deletion of one amino acid from the CFTR protein, and the 5T polymorphism is located in intron 9 and produces lower levels of an otherwise normal CFTR transcript [24] . Patients with cystic brosis are at increased lifetime risk of developing digestive tract cancers and pancreatic cancer [25] [26] [27] .
It is generally recognized that no single cancer biomarker can provide su cient information for optimal cancer diagnosis. e current trend is to focus on the identi cation of multiple biomarkers that can be used in combination. e present data provide evidence that serum CFTR should be considered as a novel biomarker for GC diagnosis. is biomarker displays higher diagnostic sensitivity to GC than commonly-used markers, such as CA199 and CEA (Table 4) . Moreover, among the 33 cancer patients who had normal levels of CA199 (< 37 U/mL), 18 of them (54%) had elevated levels of CFTR (values of 4.5 ng/mL or greater; the cuto for 95% speci city). sensitivity of GC over either measurement alone. In addition, a strong correlation between elevated CFTR levels and increasing age was observed in GC patients (Table 2) ; however, no similar correlation was observed in healthy volunteers. is indicates that the di erence in age between cancer cases and controls was not a confounding factor in the present study.
In conclusion, our results indicate that the serum CFTR has a broad application prospects for detection of GC. e combination of CFTR with CA199 and CEA would further improve the diagnostic sensitivity. e limitation of the present study should also be acknowledged: the number of GC patients was too small to generalize the outcomes and the results need to be con rmed in larger numbers of patients.
